Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nurix Therapeutics (NRIX) Net Income: 2019-2024

Historic Net Income for Nurix Therapeutics (NRIX) over the last 6 years, with Nov 2024 value amounting to -$193.6 million.

  • Nurix Therapeutics' Net Income fell 76.53% to -$86.4 million in Q3 2025 from the same period last year, while for Aug 2025 it was -$244.8 million, marking a year-over-year decrease of 38.32%. This contributed to the annual value of -$193.6 million for FY2024, which is 34.47% down from last year.
  • Nurix Therapeutics' Net Income amounted to -$193.6 million in FY2024, which was down 34.47% from -$143.9 million recorded in FY2023.
  • Over the past 5 years, Nurix Therapeutics' Net Income peaked at -$43.2 million during FY2020, and registered a low of -$193.6 million during FY2024.
  • Moreover, its 3-year median value for Net Income was -$180.4 million (2022), whereas its average is -$172.6 million.
  • Per our database at Business Quant, Nurix Therapeutics' Net Income slumped by 171.28% in 2021 and then increased by 20.19% in 2023.
  • Yearly analysis of 5 years shows Nurix Therapeutics' Net Income stood at -$43.2 million in 2020, then tumbled by 171.28% to -$117.2 million in 2021, then crashed by 53.90% to -$180.4 million in 2022, then rose by 20.19% to -$143.9 million in 2023, then slumped by 34.47% to -$193.6 million in 2024.